INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that Dr. Jacqueline Shea, INOVIO's President and CEO, and Dr. Michael Sumner, Chief Medical Officer, will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference. https://mma.prnewswire.com/media/2310866/INOVIO_v1_Logo.jpg […]

NewCalhoun County Clean Energy Facility to Advance Customer Priorities, Strengthen Electric Grid, and Offer Clean Energy Options for Regional Businesses Consumers Energy and Hecate Energy (“Hecate”) announced today that initial site work by Bechtel has begun on the 360-megawatt (MW) Sunfish Solar 2 project, progressing with a target completion date of Q2 2026. The project

(NASDAQ:HWKN), ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) — Hawkins, Inc. (Nasdaq: HWKN) today announced results for the nine months ended December 29, 2024, its third quarter of fiscal 2025. Third Quarter Fiscal Year 2025 Highlights: Record third quarter results for revenue, gross profit, operating income, and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization

(CNSX:MDMA.CN),(CNSX:MDMA),(OTC US:MDXXF),(Other OTC:MDXXF), TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company“) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo(TM) MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial and operational results for

(NASDAQ:LAES),(NASDAQ:LAESV), Geneva, Switzerland, Jan. 29, 2025 (GLOBE NEWSWIRE) — Patents cover innovations in semiconductor security, cryptographic key management, and anti-tampering mechanisms; see full portfolio here. SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that it has strategically expanded its patent pool,

(Paris:GNFT), Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 29, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its provisional financial calendar for 2025. 2025 Financial Calendar February 27, 2025 Publication of revenue and cash position

TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — The Bank of Canada's latest interest rate cut underscores its commitment to stimulating growth amid ongoing economic challenges – even as the looming tariff threat from south of the border complicates the outlook. “The central bank's decision to cut rates reflects its focus on the current state of

Double-digit Software revenue growth; Free cash flow well-exceeds full-year expectation IBM (NYSE: IBM) today announced fourth-quarter 2024 earnings results. https://mma.prnewswire.com/media/95470/ibm_logo.jpg “We closed the year with double-digit revenue growth in Software for the quarter, led by further acceleration in Red Hat. Clients globally continue to turn to IBM to transform with AI. Our generative AI book

(NASDAQ:SNEX), NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX) today announced that it will release its fiscal 2025 first quarter results after the market close on Wednesday, February 5, 2025. Management will host a conference call on Thursday, February 6, 2025 at 9:00 a.m. Eastern Time to review the Company's

(NASDAQ:LSTR), JACKSONVILLE, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ: LSTR) (“Landstar” or the “Company”) today reported basic and diluted earnings per share (“EPS”) of $1.31 in the 2024 fourth quarter on revenue of $1.209 billion. “The Landstar team of independent business owners and employees continued to perform admirably, despite the continuation